Newstral
Article
jdsupra.com on 2023-12-22 20:16
FDA Issues Draft Guidance on Providing Health Care Providers With Scientific Information on Unapproved Uses of Approved/Cleared Medical Products
Related news
- FDA Revises Guidance Concerning Scientific Communications to HCPs about Unapproved Uses of Approved/Cleared Medical Productsjdsupra.com
- FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Productsjdsupra.com
- FDA Cracks Down on Unapproved Eye Productsjdsupra.com
- UFDA issues warning to pet companies for selling unapproved antibioticsupi.com
- FDA Releases Public Inventory of Unapproved Food Additivesjdsupra.com
- FDA broadens scope on communication about unapproved uses to HCPsjdsupra.com
- FDA Issues Revised Draft Guidance on “Scientific Information on Unapproved Uses Communications”jdsupra.com
- FDA warns animal drug companies over unapproved antimicrobials, identifying “public health concerns”jdsupra.com
- Medtronic Launches FDA-Cleared OsteoCool RF Ablation Systemjdsupra.com
- MBoston Scientific gets FDA approval for spinal cord stimulator system that offers non-opioid pain treatmentmarketwatch.com
- FDA releases systematic review of the scientific literature on food safety culturejdsupra.com
- FDA Releases Its Scientific Support for Rescheduling Marijuana to Schedule IIIjdsupra.com
- FDA Proposes National Standards for Wholesale Drug Distributors and Third-Party Logistics Providersjdsupra.com
- Four Things that Healthcare Providers Need to Know About FDA Counterfeiting Investigationsjdsupra.com
- FDA cracks down on unapproved ear dropswkrg.com
- FDA pulls unapproved prescription ear dropsKnoxville News Sentinel
- FDA Cracks Down On Unapproved Ear DropsWBNS-10TV
- FDA Reinstates Unapproved New Drug Initiativejdsupra.com